Leishmania RNA virus: when the host pays the toll.

Keyphrases

• Metastasis 100%
• Mucocutaneous Leishmaniasis 100%
• Leishmania RNA Virus 1 (LRV1) 100%
• Toll-like 66%
• Leishmania Parasites 66%
• Viannia 66%
• Interferon-α (IFN-α) 33%
• Virulence 33%
• Host Cell 33%
• Disease Severity 33%
• Inflammation 33%
• Mucosa 33%
• Inflammatory Pathways 33%
• Oxidative Stress 33%
• Viral 33%
• Immunogen 33%
• Metastatic Disease 33%
• Nucleic Acids 33%
• Inflammatory State 33%
• Endosymbiosis 33%
• Human Host 33%
• RNA Virus 33%
• South America 33%
• Experimental Animal Models 33%
• Hyperinflammation 33%
• Human Sources 33%
• Metastatic Leishmaniasis 33%
• Totiviridae 33%
• Secondary Lesions 33%
• Leishmania Guyanensis 33%
• Parasitic Elements 33%
• Antileishmanial Drugs 33%
• Diagnostic Intervention 33%
• Virus Families 33%
• Clinical Interventions 33%
• Immune-inflammatory Response 33%
• Parasite Virulence 33%
• Parasite Persistence 33%
• Metastatic Complications 33%

Immunology and Microbiology

• Leishmania 100%
• RNA Virus 100%
• Parasite 100%
• Cutaneous Leishmaniasis 75%
• TLR3 50%
• Infectious Disease 50%
• Infection 50%
• interferon 25%
• Immune Response 25%
• Host Cell 25%
• Oxidative Stress 25%
• Mucosa 25%
• Experimental Animal 25%
• Leishmaniasis 25%
• Hypersensitivity 25%
• Parasite Virulence 25%
• Nose 25%
• Totiviridae 25%
• Leishmania guyanensis 25%
• Mouth 25%
• Inflammation 25%
• Virus 25%
• Symbiosis 25%